Usefulness of stable microbubble test of tracheal aspirate for the diagnosis of neonatal respiratory distress syndrome

Journal of Paediatrics and Child Health

Volumn 33, Issue 4, 1997, Pages 329-334

  Boo, N Y ^a   Cheong, K B ^b   Cheong, S K ^b   Lye, M S ^b   Zulfiqar, M A ^c  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Respiratory distress syndrome; Stable microbubble test; Tracheal aspirates

Indexed keywords

PROTEIN A; SURFACTANT;

ARTICLE; ASPIRATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MECONIUM ASPIRATION; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; RESPIRATORY DISTRESS SYNDROME;

EID: 0030824125     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01610.x     Document Type: Article

References (34)

1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 1959; 57: 517-23.
2. Hegyi T, Hiatt IM. The effect of continuous positive airway pressure on the course of respiratory distress syndrome: The benefits on early initiation. Crit. Care Med. 1981; 9: 38-41.
3. Kamper J, Ringsted C. Early treatment of idiopathic respiratory distress syndrome using binasal continous positive airway pressure. Acta Paediatr. Scand. 1990; 79: 581-6.
4. Boo NY, Nasri NM, Cheong SK, Sivamohan N. A 2-year study of neonatal mortality in a large Malaysian hospital. Singapore Med. J. 1991; 32: 142-7.
5. Soil RS, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB (eds), Effective Care of the Newborn Infants. Oxford University Press. Oxford 1992; 325-58.
6. Stark AR, Frantz ID. Respiratory distress syndrome. Pediatr. Clin. North Am. 1986; 33: 533-44.
7. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA. Ontogeny of surfactant protein A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr. Research 1991; 30: 597-605.
8. Charon A, Taeusch HW, Fitzgibbon C et al. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatr. 1989; 83: 348-54.
9. Collaborative European Multicentre Study Group. Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Eur. J. Pediatr. 1991; 150: 433-9.
10. Segerer H, Stevens P, Schadow B et al. Surfactant substitution in ventilated very low birthweight infants: Factors related to response types. Pediatr. Res. 1991; 30: 591-6.
11. Hamvas A, Devine T, Cole FS. Surfactant therapy failure identifies infants at risk for pulmonary morbidity. Am. Rev. Respir. Dis. 1993; 147: 665-8.
12. Gluck L, Kulovich MV, Borer RC, Brenner PH, Anderson CG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am. J. Obstet. Gynecol. 1971; 109: 440-5.
13. Bhagwanani SG, Fahmy D, Turnbull AC. Prediction of neonatal respiratory distress by estimation of amniotic fluid lecithin. Lancet 1972; I: 159-62.
14. Morita T, Fujiwara T. Prediction of RDS by the measurement of DSPC/S in amniotic fluid. Jpn J. Perinatal Med. 1984; 9: 757-63.
15. Shelley SA, Balis JU, Paciga JE, Knuppel RA, Ruffolo EH, Bouis PJ. Surfactant 'apoproteins' in human amniotic fluid: an enzyme-linked immunosorbent assay for the prenatal assessment of lung maturity. Am. J. Obstet. Gynecol. 1982; 144: 224-8.
16. Chida S, Phelps DS, Cordle C, Soll R, Floros J, Taeusch HW. Surfactant-associated proteins in tracheal aspirates of infants with respiratory distress syndrome after surfactant therapy. Am. Rev. Respir. Dis. 1988; 137: 943-7.
17. Gerdes JS, Abbasi S, Karp K, Hull W, Whitsett JA. Surfactant protein-A in bronchoalveolar lavage fluid from neonates with RDS on conventional and high-frequency oscillatory ventilation. Pediatr. Pulmonol. 1990; 9: 166-9.
18. Nagai H, Ogawa Y, Eguchi H et al. Pulmonary surfactant apoprotein-A in neonates with different respiratory disorders. Acta Paediatr. Jpn 1992; 34: 636-41.
19. Stevens PA, Schadow B, Bartholain S, Segerer H, Obladen M. Surfactant protein A in the course of respiratory distress syndrome. Eur. J. Pediatr. 1992; 151: 596-600.
20. Eguchi H, Koyama N, Tanaka T, Kamiya K, Ogawa Y. Surfactant apoprotein A (SP-A) in tracheal aspirates of newborn infants with RDS. Acta Paediatr. Jpn 1991; 33: 649-54.
21. Pattle RE, Kratzing CC, Parkinson CE et al. Maturity of fetal lungs tested by production of stable microbubbles in amniotic fluid. Br. J. Obstet .Gynaecol. 1979; 86: 615-22.
22. Chida S, Fujiwara T. Stable microbubble test for predicting the risk of respiratory distress syndrome: I. Comparisons with other predictors of fetal lung maturity in amniotic fluid. Eur. J. Pediatr. 1993; 152: 148-51.
23. Chida S, Fujiwara T, Konishi M, Takahashi H, Sasaki M. Stable microbubble test for predicting the risk of respiratory distress syndrome: II. Prospective evaluation of the test on amniotic fluid and gastric aspirate. Eur. J. Pediatr. 1993; 152: 152-6.
24. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard score, expanded to include extremely premature infants. J. Pediatr. 1991; 119: 417-23.
25. Marinelli P. Mean airway pressure calculation. J. Pediatr. 1981; 99: 168-9.
26. Cheong KB, Cheong SK, Boo NY, Jemilah M, Ton S.H. An in-house ELISA method for measuring surfactant protein-A. Malaysian J. Pathol. 1995; 17: 91-6.
27. Harlow E, Lane D. Antibodies - a laboratory manual. Cold Spring Harbour Laboratory, New York, 1988; 553-612.
28. Norusis MJ. SPSS 6.1 guide to data analysis. Prentice Hall, New Jersey, 1995.
29. BMDP Statistical Software Manual version 7.0. University of California, Berkeley, 1992.
30. Chen CT, Toung TJK, Rogers MC. Effect of intra-alveolar meconium on pulmonary surface tension properties. Crit. Care Med. 1985; 13: 233-6.
31. Moses D, Holm BA, Spitale P, Liu M, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am. J. Obstet. Gynecol. 1991; 164: 477-81.
32. Skelton R, Jeffery H. 'Click test': Rapid diagnosis of the respiratory distress syndrome. Pediatr. Pulmonol. 1994; 17: 383-9.
33. The OSIRIS Collaborative Group. Early vs delayed neonatal administration of a synthetic surfactant: The judgement of OSIRIS. Lancet 1992; 340: 1363-9.
34. Bevilacqua G, Halliday H, Parmigiani S, Robertson B. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group. J. Perinat. Med. 1993; 21: 329-40.